Article
Pfizer to further reduce Prevenar 13 price in poorest nations
Pfizer has announced that it will be taking new steps to make its Prevenar 13 vaccine accessible to people in poor countries through a new agreement with the Gavi Alliance. The company has committed to a 20 cent reduction of its per-dose price for the new four-dose vial presentation of the pneumococcal polysaccharide conjugate vaccine…Susan Silbermann, president and general manager of Pfizer Vaccines, said: "We are pleased to support Gavi in our shared goal of protecting the world's most vulnerable children through a sustainable vaccine programme. No child should die - anywhere in the world - from a vaccine-preventable disease."…